Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World August 29, 2012 Rebecca Trager	Presidential candidates search for the right chemistry As the US prepares for a presidential election on 6 November, science and research groups appear to backing the current incumbent President Barack Obama.
Pharmaceutical Executive February 1, 2011 Jill Wechsler	The Building Block of Drug Discovery With Francis Collins now calling the shots at NIH, will be be able to deliver on the innovations behind the genome?
National Defense February 2014 Dan Parsons	Government Scientists Fight for Funding Government scientists want to preserve the surge of cash military laboratories have used to help troops fight the wars of the last decade in hopes that ongoing experimentation will help the military prepare for conflicts to come.
BusinessWeek August 27, 2009 Adrian Slywotzky	Where Have You Gone, Bell Labs? Here's how basic research and strong leadership can repair the broken U.S. business model.
Pharmaceutical Executive September 1, 2011 Richard Barker	Innovating Around Innovation The former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.
IndustryWeek April 1, 2005 Patricia Panchak	Editor's Page -- Playing The R&D Blame Game The Bush Administration's 2006 budget short-changes industrial research and development. Industry executives and shareholders have also contributed to a slowing of spending on basic research.
IndustryWeek August 1, 2003 John Teresko	Fearing R&D's Flight Research and development is an increasingly crucial factor in sustaining the competitiveness of U.S. manufacturing amid rapid globalization. Yet experts warn that strategic missteps endanger U.S. technological preeminence.
IndustryWeek August 1, 2003 John Teresko	Technology Brokering, An R&D Checklist List offers ways to convert R&D laboratories into technology brokers.
HBS Working Knowledge March 20, 2006 Huston & Sakkab	P&G's New Innovation Model Procter & Gamble's assessment of its aging innovation process and the development of connect and develop.
Pharmaceutical Executive June 1, 2005 Jan Malek	When Two Heads are Better R&D president isn't one job-it's two. By appointing COOs for R&D with broad operational mandates, biotech and pharmaceutical companies can ensure that operational issues get the attention they urgently require.
IEEE Spectrum July 2005 Michael Riordan	The End of AT&T In 1974 AT&T was the world's largest corporation and research arm Bell Labs provided a constant flow of technological break-throughs due to long-term stable funding. There is no comparable situation today.
IndustryWeek January 1, 2005 Patricia Panchak	Fund The Future To make U.S. companies and the workers they employ more competitive, policymakers have to think in terms of investing in the industries of the future, not those of the past.
National Defense March 2015 Sandra Erwin	Defense Department Takes Steps to Energize Cutting-Edge Research The Defense Department is reorganizing its technology shop as it tries to light a fire under its science programs.
Wired December 22, 2008 David Goldston	Science We Can Believe In: How President Obama Can Recharge US Research With the economy in tumult and a deficit that could reach $1 trillion this year, the question is not whether research and development should be a priority but whether Obama will be able to deliver.
IndustryWeek August 1, 2006 John Teresko	Recapturing R&D Leadership If maintaining U.S. R&D leadership is the goal, then both government support and industry practices need to be reconsidered.
Chemistry World July 1, 2008 Rebecca Trager	US research agencies get extra millions The US research community has won an extra $400 million for four science agencies, after successfully arguing that the nation's scientific enterprise is in a state of emergency.
Pharmaceutical Executive September 1, 2012 Roy F. Waldron	Open Innovation in Pharma: Defining the Dialogue There is much talk today about "open innovation" in business and research forums, but what exactly does it mean? How does open innovation as a concept apply to the pharmaceutical sector?
IndustryWeek April 21, 2010	The Competitive Edge -- Is U.S. R&D Investment Holding Up? Data trends suggest that U.S. dominance of high-technology manufacturing is under pressure.
BusinessWeek May 17, 2004 Michael Mandel	In Praise Of Heady Growth In this book excerpt, the author argues that the economic future of the U.S. is inextricably linked to our ability to come up with more technological breakthroughs that equal the Internet in magnitude.
Pharmaceutical Executive September 1, 2010	Explaining the Drug Drought Industry needs to engage in a broader public debate on ways to rekindle the innovative engine in new drug discovery and development.
Bio-IT World October 2006 Eric K. Neumann	The Advantages of a Drug Safety Commons Once a Drug Safety Commons has been established, a variety of derivative applications will be developed that can access as well as update the information in organized ways and used by industry researchers internally.
IEEE Spectrum December 2005 Hira & Goldstein	R&D 100 Automakers top the list, drug companies trim back, and telecoms continue to gut their research budgets.
BusinessWeek August 27, 2009 Adrian Slywotzky	How Science Can Create Millions of New Jobs Reigniting basic research can repair the broken U.S. business model and put Americans back to work.
National Defense November 2007 Sandra I. Erwin	Defense Department Should Refocus Technology Spending, Experts Warn Investments in technology tend to miss the mark and do little to enhance the United States' competitive standing as a high-tech powerhouse, said Pentagon advisors and outside analysts.
InternetNews December 27, 2007 Nicholas Carlson	Political Web: A Promise Not Yet Fulfilled Wasn't the Internet supposed to reshape politics? A look at how the presidential candidates used the Web in 2007, and what they plan for the future.
The Motley Fool March 15, 2007 Chuck Saletta	The American Century Is Over As more R&D takes place overseas, the technological advances and profits will follow. So should investors.
Chemistry World January 28, 2011 Rebecca Trager	US cost savings must spare science, Obama says President Obama, in his January State of the Union speech, sought to calm concerns that major budget deficit reduction efforts will mean steep cuts for science agencies and researchers who depend on their grants.
IndustryWeek July 22, 2009 Josh Cable	Holding the Line on R&D Through steady commitment to R&D and careful scrutiny of projects' objectives, manufacturers such as Parker Hannifin and Texas Instruments are ensuring that innovation doesn't become a victim of the economic downturn.
IndustryWeek May 1, 2008 John Teresko	The Future of R&D: Leveraging Innovation Contrary to conventional thinking, R&D is a very manageable driver of corporate success.
IEEE Spectrum December 2007 Hira & Ross	The R&D 100 A company's research budget tells you very little about its prospects.
Pharmaceutical Executive January 1, 2012 William Looney	Pharma 2012: Hard Times Before the Harvest 2012 will be a transition year for pharma, one of the most important in its history. The challenge is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.
IEEE Spectrum April 2011 G. Pascal Zachary	Jobless Innovation? As the United States tries to ride high tech out of recession, does it risk innovating its workforce out of jobs?
Chemistry World April 30, 2009 Rebecca Trager	Obama issues scientific call to arms President Obama has pledged billions of extra dollars towards scientific research and development (R&D) in a bid to maintain the US's position at the forefront of science and technology.
Geotimes November 2004	Open Access: Open Debate? Imagine any U.S. citizen having free and open access to research funded with tax dollars. That possibility could be closer to reality than ever before, but Congress must first address some important concerns
Chemistry World December 10, 2012 Andrew Turley	EU companies increasing R&D Companies in the EU are increasing their investment in R&D, despite the difficult economic conditions, according to a report from the European Commission that looked at the global top 1500 R&D investors.
Chemistry World March 7, 2014 Rebecca Trager	Obama's proposed science budget disappoints US researchers and science advocates are expressing significant disappointment at funding proposals for research agencies in President Obama's budget request for 2015.
HBS Working Knowledge September 19, 2012 Carmen Nobel	Funding Innovation: Is Your Firm Doing it Wrong? Many companies are at a loss about how to fund innovation successfully. In his new book, The Architecture of Innovation, Professor Josh Lerner starts with this advice: get the incentives right.
Chemistry World November 21, 2014 Rebecca Trager	China poised to become top science spender China is on track to become the world's top R&D spender before the end of the decade, according to a new report released by the Organization for Economic Cooperation and Development.
Pharmaceutical Executive October 1, 2012 Ben Comer	The Drug Vote 2012 A comparative effectiveness study on the two presidential candidates.
BusinessWeek December 8, 2003 Michael J. Mandel	Commentary: Meeting the Asian Challenge As India and China ascend the economic ladder, here are steps that America can take to boost the four key components of innovation: R&D spending, education, finance for invention, and the national willingness to take risks.
IEEE Spectrum November 2008 Hira & Ross	R&D Goes Global Hidden in corporate research budgets is a shift of R&D work to low-cost countries, particularly China and India.
Chemistry World December 23, 2014 Rebecca Trager	US research agencies finally learn their fate US science agencies have finally received their 2015 budgets, more than two months after the start of the fiscal year, and the numbers drew a mixed response from science groups and the research lobby.
BusinessWeek October 29, 2009 Michael Mandel	The GDP Mirage By overlooking cuts in research and development, product design, and worker training, GDP is greatly overstating the economy's strength.
Chemistry World November 17, 2010 Rebecca Trager	US science agencies poised for tough times Current political and economic conditions in the US could mean bad news for the nation's science agencies and the researchers.
Pharmaceutical Executive October 1, 2006 Sarah Houlton	Global Report: Please Come Back Health authorities in Europe are working hard to reestablish their countries as preferred locations for pharma's R&D facilities. Fortunately, they've got a blueprint: China.
Military & Aerospace Electronics July 2004 John Rhea	Outlook Uneasy for Federal Science Support Given the current unsettled nature of the nation's economy, companies in the advanced-technology industries are going to have to do some serious scouting if they hope to maintain a healthy federal government business.
IndustryWeek September 1, 2006 Jill Jusko	Research & Development: Smarter Spending With limited R&D resources but plenty of new product concepts, manufacturers are learning to focus on affordable product strategies.
Pharmaceutical Executive July 1, 2013 Richie Etwaru	Innovation Calls Across the C-suite: Lessons From Wall Street The lifeblood of the life sciences industry is continuous innovation; it is not a business that can survive by standing still.
Chemistry World September 9, 2014 Hepeng Jia	R&D share for basic research in China dwindles Although China has dramatically increased its science and technology spending in recent years, the proportion of the research budget being spent on basic and applied research is shrinking.
IndustryWeek May 1, 2005 John Teresko	Pipeline = Lifeline Researchers say 70% of today's manufactured goods will be obsolete in six years, and that companies with strong enabling R&D strategies to add new products are 73% more profitable.